TSE:CMED

(CMED.TO) Stock Forecast, Price & News

Add

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume52,208 shs

Average Volume387,394 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

CanniMed Therapeutics Inc. operates as a plant biopharmaceutical company that specializes in medical cannabis. The company cultivates and sells pharmaceutical-grade cannabis products in dried herbal and oil forms for Canadian patients. It also offers herbal cannabis and cannabis oil; and vaporizers, consumable vaporizer accessories, and herb mills. In addition, the company offers a plant biotechnology research and product development program that focuses on the production of plant-based materials for pharmaceutical, agricultural, and environmental applications. CanniMed Therapeutics Inc. was founded in 1988 and is based in Saskatoon, Canada. As of March 28, 2018, CanniMed Therapeutics Inc. operates as a subsidiary of Aurora Cannabis Inc.

Headlines

Apex Legends Persistence Read Complete Error: How to Fix
January 3, 2021 | msn.com

Air India pilots reject 5% rollback in pay cut, ask Air India CMD to donate it towards Parliament building or PM Care
December 24, 2020 | msn.com

BACKSTORY: How Ujala's parent bought Henkel - by doubling offer even before starting talks
November 11, 2020 | msn.com

BACKSTORY: How Ujala's parent bought Henkel - by doubling its offer before even talking to it
November 11, 2020 | msn.com

BACKSTORY: When a white envelope helped seal the Jyothy-Henkel deal
November 9, 2020 | msn.com

Why Aurora Cannabis Is Trading Higher Today - Benzinga
September 22, 2020 | benzinga.com

Aurora Cannabis to Host Fourth Quarter and Full Fiscal Year 2020 Investor Conference Call and Related Year End Informational Filings - Yahoo Finance
September 14, 2020 | finance.yahoo.com

Aurora Cannabis Inc. (ACB) Appoints Miguel Martin as CEO - StreetInsider.com
September 9, 2020 | streetinsider.com

CTT Pharma Files Statement of Claim against Aurora Cannabis and Appoints Dr. Shane Morris to Advisory Board - StreetInsider.com
August 29, 2020 | streetinsider.com

Why the November Elections Could Be Huge for Top Marijuana Stocks - 24/7 Wall St.
July 31, 2020 | 247wallst.com

Brent Zettl donates $300K to Ag-West Bio's ABIC Foundation to fund Beyond Entrepreneurship training program - Business Wire
June 27, 2020 | www.businesswire.com

Brent Zettl donates $300K to Ag-West Bio's ABIC Foundation to fund Beyond Entrepreneurship training program - StreetInsider.com
June 25, 2020 | www.streetinsider.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange TSE

Industry N/A

Sub-IndustryCannabis

SectorN/A

Current SymbolTSE:CMED

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.cannimedtherapeutics.com

Phone+1-306-9751207

EmployeesN/A

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares24,757,000

Market CapN/A

Next Earnings DateN/A

OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.62 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for (CMED.TO).

3.1 Community Rank

Outperform Votes
(CMED.TO) has received 157 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
(CMED.TO) has received 100 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
(CMED.TO) has received 61.09% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about (CMED.TO) and other stocks. Vote “Outperform” if you believe CMED will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CMED will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
(CMED.TO) does not currently pay a dividend.
Dividend Growth
(CMED.TO) does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, (CMED.TO) insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

30 days | 90 days | 365 days | Advanced Chart

Receive CMED News and Ratings via Email

Sign-up to receive the latest news and ratings for CMED and its competitors with MarketBeat's FREE daily newsletter.

(CMED.TO) (TSE:CMED) Frequently Asked Questions

What stocks does MarketBeat like better than (CMED.TO)?

Wall Street analysts have given (CMED.TO) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but (CMED.TO) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are (CMED.TO)'s key executives?

(CMED.TO)'s management team includes the following people:

Mr. Andre Jerome, CEO & Director
Mr. John Lewis Knowles BComm., CPA, C.A., CFO, Corp. Sec. & Non-Independent Director (Age 63)
Mr. Howard Harkness, VP of Marketing & Sales

Who are some of (CMED.TO)'s key competitors?

Some companies that are related to (CMED.TO) include Canopy Growth (WEED), Innovative Industrial Properties (IIPR), Leaf Mobile (LEAF), GrowGeneration (GRWG), OrganiGram Holdings Inc. (OGI.TO) (OGI), 22nd Century Group (XXII), NSAV (NSAV), Emblem (EMC), ICC Labs (ICC), Bioventix (BVXP), KushCo (KSHB), Terra Tech (TRTC), General Cannabis (CANN), Grow Capital (GRWC) and Leafbuyer Technologies (LBUY).
View all of CMED's competitors.

What other stocks do shareholders of (CMED.TO) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (CMED.TO) investors own include Aurora Cannabis Inc. (ACB.TO) (ACB), Canopy Growth (WEED), Smith & Nephew (SNN), (THCX.V) (THCX), CannTrust (CTST), Cronos Group (CRON), (MJN.V) (MJN), CannaRoyalty (CNNRF), KushCo (KSHB) and Leaf Mobile (LEAF).

What is (CMED.TO)'s stock symbol?

(CMED.TO) trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CMED."

How do I buy shares of (CMED.TO)?

Shares of CMED and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

How much money does (CMED.TO) make?

(CMED.TO) has a market capitalization of C$0.00.

What is (CMED.TO)'s official website?

The official website for (CMED.TO) is www.cannimedtherapeutics.com.

Where are (CMED.TO)'s headquarters?

(CMED.TO) is headquartered at 1 Plant Technology Road, Box 19A, RR #5, SASKATOON, SK S7K 3J8, Canada.

How can I contact (CMED.TO)?

(CMED.TO)'s mailing address is 1 Plant Technology Road, Box 19A, RR #5, SASKATOON, SK S7K 3J8, Canada. The company can be reached via phone at +1-306-9751207.

This page was last updated on 3/1/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here